Deals & Cases

10 von 571 Einträgen wurden gefunden.
2020-02-10

On January 30, 2020, Credit Suisse AG (Credit Suisse) launched, and on February 4, 2020 successfully completed, its registered offering of USD 2 bn aggregate principal amount of floating rate senior notes due 2022 (the Notes).

On January 30, 2020, Credit Suisse AG (Credit Suisse) launched, and on February 4, 2020 successfully completed, its registered offering of USD 2 bn aggregate principal amount of floating rate senior notes due 2022 (the Notes). The Notes were issued under Credit Suisse's U.S. medium-term note program and pursuant to its shelf registration statement of file with the U.S. Securities and Exchange Commission.


The floating rate of interest applicable to the Notes, which is reset quarterly, is determined by reference to Compounded Daily SOFR, which is based on the daily Secured Overnight Financing Rate (SOFR), the proposed alternative reference rate to U.S. dollar LIBOR.


Homburger advised Credit Suisse with respect to all aspects of Swiss law. The Homburger team was led by partner René Bösch (Capital Markets) and included partners Benjamin Leisinger (Capital Markets) and Dieter Grünblatt (Tax), as well as counsel Lee Saladino (Capital Markets).


Mehr lesen
2020-02-06

On January 29, 2020, UBS Group AG (UBS) successfully completed its issuance of EUR 1.5 bn principal amount of Fixed Rate/Fixed Rate Senior Notes (the Notes) under its Senior Debt Programme.

On January 29, 2020, UBS Group AG (UBS) successfully completed its issuance of EUR 1.5 bn principal amount of Fixed Rate/Fixed Rate Senior Notes (the Notes) under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS's Swiss gone concern requirement.


The Notes have been provisionally admitted to trading, and application has been made for admission to trading and listing of the Notes, on the SIX Swiss Exchange.


Homburger advised UBS with respect to all regulatory and transactional aspects of Swiss law. The Homburger team included partners Benedikt Maurenbrecher, Stefan Kramer (both Banking and Finance | Capital Markets) and Stefan Oesterhelt (Tax), as well as counsel Lee Saladino and associate Olivier Baum (both Banking and Finance | Capital Markets).

Mehr lesen
2020-02-05

On January 15, 2020, Zurich Insurance Company Ltd (Zurich) and CSS Versicherung AG (CSS) announced that Zurich acquired the corporate accident & health portfolio of CSS.

On January 15, 2020, Zurich Insurance Company Ltd (Zurich) and CSS Versicherung AG (CSS) announced that Zurich acquired the corporate accident & health portfolio of CSS.


About 30,000 customers with insurance policies in the daily sickness benefits insurance, the mandatory accident insurance as well as in the supplementary accident insurance will thus transfer from CSS to Zurich. In addition, CSS' employees of the corporate clients business will also change to Zurich. The acquisition underscores Zurich's strategy of continuously expanding its position in the corporate clients business and further diversifying its business portfolio.


The transfer of the insurance portfolio is subject to merger control clearance by the Swiss Competition Commission (COMCO) and to the approval of the Swiss Financial Market Supervisory Authority FINMA (FINMA).


The Homburger team advising Zurich in this transaction was led by partner Hansjürg Appenzeller (Corporate | M&A and Insurance) and included associate Daniel Kuhn (Corporate | M&A) as well as partners Luca Dal Molin (IP | IT) and Richard Stäuber (Competition | Regulatory). Associates Fabian Meier (Banking and Finance, Insurance), Valentin Fluor (IP | IT) and Yves Bianchi (Competition | Regulatory) as well as junior associates Urs Stürmer (Corporate | M&A) and Oriana Schöni (Competition | Regulatory) also contributed to the transaction.


Mehr lesen
2020-01-29

On January 29, 2020, Addex Therapeutics Ltd (Addex) (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced the listing of American Depositary Shares (ADSs) representing its ordinary shares on the Nasdaq Stock Market.

On January 29, 2020, Addex Therapeutics Ltd (Addex) (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced the listing of American Depositary Shares (ADSs) representing its ordinary shares on the Nasdaq Stock Market. The ADSs will be listed for trading on Nasdaq under the symbol "ADXN" on January 29, 2020.


Homburger advised Addex with respect to the Swiss legal aspects of the listing. The Homburger team comprised partner Frank Gerhard and associate Guy Deillon (both Corporate | M&A and Capital Markets).

Mehr lesen
2020-01-28

On January 15, 2020, Credit Suisse Group AG (CSG) launched, and on January 24, 2020, CSG successfully completed, the issuance of USD 1 bn 5.100 per cent. Perpetual Tier 1 Contingent Write-down Capital Notes (the Notes).

On January 15, 2020, Credit Suisse Group AG (CSG) launched, and on January 24, 2020, CSG successfully completed, the issuance of USD 1 bn 5.100 per cent. Perpetual Tier 1 Contingent Write-down Capital Notes (the Notes). The Notes are "high trigger" regulatory capital instruments that are eligible to fulfill CSG's Swiss going concern requirements.


The Notes are governed by Swiss law, and have been provisionally admitted to trading, and application has been made for trading and listing of the Notes, on the SIX Swiss Exchange.


Homburger advised Credit Suisse with respect to all aspects of Swiss law. The Homburger team was led by partner René Bösch (Capital Markets) and included partners Benjamin Leisinger (Capital Markets) and Dieter Grünblatt (Tax), as well as counsel Lee Saladino (Capital Markets) and paralegal Ganna Goncharova (Capital Markets).

Mehr lesen
2020-01-23

On January 14, 2020, Credit Suisse Group AG (Credit Suisse) successfully completed the issuance of EUR 1.25 bn 0.650% Fixed Rate Reset Senior Callable Notes due 2028 (the Notes) under its Euro Medium Term Note (EMTN) Programme.

On January 14, 2020, Credit Suisse Group AG (Credit Suisse) successfully completed the issuance of EUR 1.25 bn 0.650% Fixed Rate Reset Senior Callable Notes due 2028 (the Notes) under its Euro Medium Term Note (EMTN) Programme. The Notes are bail-inable bonds that are eligible to count towards Credit Suisse's Swiss gone concern requirement.


The Notes have been provisionally admitted to trading, and application has been made for admission and listing of the Notes, on the SIX Swiss Exchange.


Homburger advised Credit Suisse with respect to all aspects of Swiss law. The Homburger team was led by partner René Bösch (Capital Markets) and included partners Benjamin Leisinger (Capital Markets) and Dieter Grünblatt (Tax), as well as counsel Lee Saladino and associate Andrea Ziswiler (both Capital Markets).

Mehr lesen
2020-01-22

On January 22, 2020, Amun AG (Amun), a Zug-based special purpose issuance vehicle of the fintech group Amun, successfully issued and listed a new Series of Products (Ticker: SBTC) on the SIX Swiss Exchange.

On January 22, 2020, Amun AG (Amun), a Zug-based special purpose issuance vehicle of the fintech group Amun, successfully issued and listed a new Series of Products (Ticker: SBTC) on the SIX Swiss Exchange. These Products, the "21Shares Short Bitcoin ETP" are linked to the inverse performance of Bitcoin (BTC) and allow a -1x exposure to Bitcoin (BTC)'s performance on a daily basis. The purpose of this Product is to allow investors to, on a short-term basis, benefit from a negative development in the value of Bitcoin (BTC), the largest cryptocurrency.


Homburger advised Amun with respect to all aspects of Swiss law. The Homburger team was led by partner Benjamin Leisinger (Capital Markets) and comprised associates Urs Meier (Banking and Finance, Technology and Digital Economy) and Stefan Bindschedler (Banking and Finance) as well as paralegal Ganna Goncharova (Banking and Finance).

Mehr lesen
2020-01-13

On January 7, 2020, NewAlpha Asset Management and Capital Croissance announced that BIOBank, a French human origin bone bank, acquired Neutromedics AG, a Swiss distributor of orthobiologics and orthopedic implants.

On January 7, 2020, NewAlpha Asset Management and Capital Croissance announced that BIOBank, a French human origin bone bank, acquired Neutromedics AG, a Swiss distributor of orthobiologics and orthopedic implants. BIOBank, a portfolio company of the growth equity fund NewAlpha Verto and of a fund managed by Capital Croissance, accelerates its international development with this first external growth transaction.


The Homburger team advising BIOBank in this transaction was led by partner Daniel Hasler (Corporate | M&A) and included associate Margrit Marti (Corporate | M&A), partner Franz Hoffet and associate Yves Bianchi (both Competition | Regulatory), counsel Peter Müller (Tax), associates Aliénor de Dardel (Employment and Executive Compensation) and Andrea Ziswiler (Banking and Finance) as well as junior associate Gregor Schifferle (Corporate | M&A).

Mehr lesen
2020-01-10

Homburger advised IMA Medtech SA (IMA Medtech), a company active in the automation industry, in connection with the acquisition of Sysmelec, a business unit of Unitechnologies SA.

Homburger advised IMA Medtech SA (IMA Medtech), a company active in the automation industry, in connection with the acquisition of Sysmelec, a business unit of Unitechnologies SA. Sysmelec is a leading company in the design and manufacturing of turnkey solutions for micro assembly and watchmaking industries.


Homburger advised IMA Medtech with respect to all aspects of Swiss Law. The Homburger team was led by partner Dieter Gericke, and included associate Angela Oppliger and junior associates Michael Lüchinger and Nicolas Eckert (all Corporate | M&A) as well as partner Stefan Oesterhelt and associate Manuel Dubach (both Tax).

Mehr lesen
2020-01-08

On January 7, 2020, three USD-denominated Exchange Traded Products (ETPs) of Amun AG (Amun), a Zug-based special purpose issuance vehicle of the fintech group Amun, successfully started their trading on the SIX Swiss Exchange in additional trading currencies.

On January 7, 2020, three USD-denominated Exchange Traded Products (ETPs) of Amun AG (Amun), a Zug-based special purpose issuance vehicle of the fintech group Amun, successfully started their trading on the SIX Swiss Exchange in additional trading currencies. These products (Tickers: HODL, ABTC, and AETH) are linked to the performance of a basket of, or in the case of ABTC and AETH individual, crypto underlyings. The USD-denominated products will newly also be quoted in EUR (all products) and Swiss Francs (in the case of ABTC and AETH only) to further increase the attractiveness to EEA and Swiss investors. Each product is fully collateralized by the respective underlying, which is stored with an independent custodian.


Homburger advised Amun with respect to all aspects of Swiss law. The Homburger team was led by partner Benjamin Leisinger (Capital Markets and Banking and Finance) and comprised counsel Eduard De Zordi and paralegal Ganna Goncharova (both Banking and Finance).

Mehr lesen